Performance of the New Bayer VERSANT HCV RNA 3.0 Assay for Quantitation of Hepatitis C Virus RNA in Plasma and Serum: Conversion to International Units and Comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, Assay

We have evaluated the VERSANT HCV RNA 3.0. Assay (HCV 3.0 bDNA assay) (Bayer Diagnostics, Berkeley, Calif.), which is an improved signal amplification procedure for the HCV 2.0 bDNA assay for the quantitation of hepatitis C virus (HCV) RNA in serum or plasma of HCV-infected individuals. The HCV 3.0...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Beld, Marcel, Sentjens, Roel, Rebers, Sjoerd, Weegink, Christine, Weel, Jan, Sol, Cees, Boom, René
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2002
Materias:
Virology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC120248/
https://ncbi.nlm.nih.gov/pubmed/11880394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.40.3.788-793.2002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares